New treatment option for Dementia
Official title Connecting Caregivers With Community Services: The Care Buddy Platform
ClinicalTrials.gov ID: NCT06817876
What this study is testing
- What it's testing
- The study aims to develop a mobile-app (Care Buddy) which will be a one-stop integrated source of information and technology-based solutions for caregivers of people with dementia (PWDs). Study aims to bring caregivers into closer partnerships with the wider ecosystem (e.g., healthcare practitioners, community services, peer support, and care service providers) which will ultimately improve outcomes for both PWDs and their caregivers.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 80. Healthy volunteers may be eligible.
You may be able to join if
- The for patients are
- Singaporean/Permanent residents
- Age 21 years of age or older
- Main person or one of the main persons involved in making decisions regarding treatment patient receives or responsible for ensuring the well-being...
- An active primary caregiver for at least 6 months, and planning to remain the primary caregiver for the next 2 years
You likely can't join if
- Caregivers of patients staying in nursing home or other long-term care facility with no intention of being discharged will not be eligible however...
See the full eligibility criteria
- The for patients are
- Singaporean/Permanent residents
- Age 21 years of age or older
- Main person or one of the main persons involved in making decisions regarding treatment patient receives or responsible for ensuring the well-being of the patient
- An active primary caregiver for at least 6 months, and planning to remain the primary caregiver for the next 2 years
- Is a family member of the patient with dementia
- Can read and write in English
- Accessible by telephone to schedule interviews
- Has familiarity with use of technology (e.g., computers, tablets, or internet) and is able to complete surveys, forms using digital technology
- Intact cognition determined through the Abbreviated Mental Test (AMT) for those who are ≥ 65 years old.
- Caregivers who score \>=9 on the 6-item Zarit Burden scale
- Caregivers of patients staying in nursing home or other long-term care facility with no intention of being discharged will not be eligible however, if the patient is admitted to respite care for short/long term duration...
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore, Singapore
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.